Rubius Therapeutics, Inc.
Records under this name other than the patents Rubius Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Rubius Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,141,433 | Therapeutic Cell Systems and Methods for Treating Cancer and Infectious Diseases Lapsed on the fee record Ended Oct 12, 2025 · High confidence | Lapsed on the fee record | Ended Oct 12, 2025 | High confidence |
| US 11,020,435 | Functionalized Erythroid Cells Lapsed on the fee record Ended Jun 1, 2025 · High confidence | Lapsed on the fee record | Ended Jun 1, 2025 | High confidence |
| US 9,644,180 | Synthetic Membrane-Receiver Complexes Lapsed on the fee record Ended May 9, 2025 · Medium confidence | Lapsed on the fee record | Ended May 9, 2025 | Medium confidence |
| US 10,869,898 | Methods and Compositions for Immunomodulation Lapsed on the fee record Ended Dec 22, 2024 · High confidence | Lapsed on the fee record | Ended Dec 22, 2024 | High confidence |
| US 10,716,811 | Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Cancer Indications Lapsed on the fee record Ended Jul 21, 2024 · High confidence | Lapsed on the fee record | Ended Jul 21, 2024 | High confidence |
| US 10,568,910 | Compositions and Methods Related to Engineered Erythroid Cells Comprising IL-15 Lapsed on the fee record Ended Feb 25, 2024 · High confidence | Lapsed on the fee record | Ended Feb 25, 2024 | High confidence |
| US 10,557,119 | Erythroid Cells Comprising Phenylalanine Ammonia Lyase Lapsed on the fee record Ended Feb 11, 2024 · Medium confidence | Lapsed on the fee record | Ended Feb 11, 2024 | Medium confidence |
| US 10,517,897 | Methods Related to Engineered Erythoid Cells Comprising 4-1BBL Lapsed on the fee record Ended Dec 31, 2023 · High confidence | Lapsed on the fee record | Ended Dec 31, 2023 | High confidence |
| US 10,456,421 | Compositions and Methods Related to Engineered Erythoid Cells Comprising 4-1BBL Lapsed on the fee record Ended Oct 29, 2023 · High confidence | Lapsed on the fee record | Ended Oct 29, 2023 | High confidence |
| 14/581,486 | Synthetic Membrane-Receiver Complexes Abandoned Abandoned Feb 14, 2017 | Abandoned | Abandoned Feb 14, 2017 |